Yan Huang, Shuang Dai, Wenlian Yin, Feng Luo, Yan Li. Sustained Clinical Response to 4th-Line Therapy with Selpercatinib in RET Fusion-Positive Combined Small Cell Lung Cancer.OncoTargets and therapy. 2023, 16: 1015-1020
. miR-188-5p Promotes Tumor Growth by Targeting CD2AP Through PI3K/AKT/mTOR Signaling in Children with Acute Promyelocytic Leukemia [Retraction].OncoTargets and therapy. 2023, 16: 1025-1026
. ST6GAL2 Downregulation Inhibits Cell Adhesion and Invasion and is Associated with Improved Patient Survival in Breast Cancer [Retraction].OncoTargets and therapy. 2023, 16: 1053-1054
Xiaoli Zhao, Mengze Hao, Xiaoyu Zhang, Jialin Wei, Sizhou Feng, Yi He, Erlie Jiang, Mingzhe Han. Post-HSCT Maintenance Treatment Using Entrectinib for an AML Patient Accompanied with ETV6::NTRK3: A Case Report.OncoTargets and therapy. 2023, 16: 1055-1059
Anqing Zhang, Liqin Zhang, Xia Xie, Dan Liu. Inhibition of ATM with KU-55933 Sensitizes Endometrial Cancer Cell Lines to Olaparib.OncoTargets and therapy. 2023, 16: 1061-1071
Samuel A Kerk, Javier Garcia-Bermudez, Kivanc Birsoy, Mara H Sherman, Yatrik M Shah, Costas A Lyssiotis. Spotlight on GOT2 in Cancer Metabolism.OncoTargets and therapy. 2023, 16: 695-702
Zhaopeng Li, Deyong Bu, Xiaobin Wang, Lin Zhu, Daoyan Lei, Fengling Tang, Xianghua Sun, Cheng Chen, Xiang Ji, Song Bai. Chidamide and Oxaliplatin Synergistically Inhibit Colorectal Cancer Growth by Regulating the RPS27A-MDM2-P53 Axis.OncoTargets and therapy. 2023, 16: 703-721